Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
52-week extension study of vildagliptin added to insulin in type 2 diabetes mellitus
2004-001979-18Phase 3Completed
- Sponsor
- Novartis
- Start
- Nov 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing vildagliptin + insulin with placebo + insulin (2 arms). Started Nov 2004; status: completed.
02
Drugs
vildagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2004-001979-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001979-18.